Effect of treadmill exercise on glutamate transporter proteins and acetylcholinesterase activity in the prefrontal cortex of diabetic rats

authors:

avatar Moslem Mohammadi , *

Koomesh: Vol.25, issue 3; 378-384
published online: August 11, 2023
article type: Research Article
received: May 02, 2023
accepted: July 05, 2023

how to cite: Mohammadi M. Effect of treadmill exercise on glutamate transporter proteins and acetylcholinesterase activity in the prefrontal cortex of diabetic rats. koomesh. 2023;25(3):e152836. 

Abstract

Introduction: Diabetes-induced neurological disorders could be attributed to changes in the neurotransmitter systems. To determine the effects of diabetes mellitus and physical activity on the brain's glutamatergic and cholinergic systems, the levels of glutamate transporter proteins and acetylcholinesterase activity were investigated in the prefrontal cortex of diabetic animals with/without treadmill exercise. Materials and Methods: Adult Wistar rats (5 rats/group) were used in this study. Diabetes mellitus was induced by intraperitoneal injection of streptozotocin (60 mg/kg). Control animals received 0.1 M citrate buffer as vehicle. After 14 days, animals were randomly divided into non-exercise and exercise groups. In the exercise groups, animals were subjected to 4 weeks of treadmill exercise (5 days per week). Thereafter, animals were sacrificed and prefrontal cortices were isolated to measure protein levels of astrocytic (GLAST and GLT-1) and neuronal (EAAC1) glutamate transporters and acetylcholinesterase (AChE) activity. Results: Animals in the diabetic group had higher GLAST and lower EAAC1 levels (P<0.001) compared to the control group, whereas the level of GLT-1 remained unchanged. In addition, a significant decrease in AChE activity was observed in the diabetic group compared to the control group (P<0.001). Treadmill exercise decreased GLAST level (P<0.05) and increased EAAC1 level and AChE activity to the normal levels in the diabetic group. Conclusion: Despite no significant effect on the elevated level of GLAST, treadmill exercise was able to restore decreased EAAC1 protein and acetylcholinesterase activity observed in the prefrontal of diabetic animals to the control levels.

References

  • 1.

    Schuster DP, Duvuuri V. Diabetes mellitus. Clin Podiatr Med Surg 2002; 19: 79-107.

  • 2.

    Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract 2022; 183: 109.

  • 3.

    de Senna PN, Ilha J, Baptista PP, do Nascimento PS, Leite MC, Paim MF, et al. Effects of physical exercise on spatial memory and astroglial alterations in the hippocampus of diabetic rats. Metab Brain Dis 2011; 26: 269-279.

  • 4.

    Kodl CT, Seaquist ER. Cognitive dysfunction and diabetes mellitus. Endocr Rev 2008; 29: 494-511.

  • 5.

    van Sloten TT, Sedaghat S, Carnethon MR, Launer LJ, Stehouwer CDA. Cerebral microvascular complications of type 2 diabetes: stroke, cognitive dysfunction, and depression. Lancet Diabetes Endocrinol 2020; 8: 325-336.

  • 6.

    Caletti G, Herrmann AP, Pulcinelli RR, Steffens L, Mors AM, Vianna P, et al. Taurine counteracts the neurotoxic effects of streptozotocin-induced diabetes in rats. Amino Acids 2018; 50: 95-104.

  • 7.

    Erukainure OL, Ijomone OM, Oyebode OA, Chukwuma CI, Aschner M, Islam MS. Hyperglycemia-induced oxidative brain injury: Therapeutic effects of Cola nitida infusion against redox imbalance, cerebellar neuronal insults, and upregulated Nrf2 expression in type 2 diabetic rats. Food Chem Toxicol 2019; 127: 206-217.

  • 8.

    Rahigude A, Bhutada P, Kaulaskar S, Aswar M, Otari K. Participation of antioxidant and cholinergic system in protective effect of naringenin against type-2 diabetes-induced memory dysfunction in rats. Neuroscience 2012; 226: 62-72.

  • 9.

    Wang C, Li J, Zhao S, Huang L. Diabetic encephalopathy causes the imbalance of neural activities between hippocampal glutamatergic neurons and GABAergic neurons in mice. Brain Res 2020; 1742: 146863.

  • 10.

    Pignalosa FC, Desiderio A, Mirra P, Nigro C, Perruolo G, Ulianich L, et al. Diabetes and cognitive impairment: A role for glucotoxicity and dopaminergic dysfunction. Int J Mol Sci 2021; 22.

  • 11.

    Gandhi GK, Ball KK, Cruz NF, Dienel GA. Hyperglycaemia and diabetes impair gap junctional communication among astrocytes. ASN Neuro 2010; 2: e00030.

  • 12.

    Pitsikas N. The metabotropic glutamate receptors: potential drug targets for the treatment of anxiety disorders? Eur J Pharmacol 2014; 723: 181-184.

  • 13.

    Mohammadi M, Zare Z, Allah-Moradi E, Vaezi N, Valadan R, Tehrani M. Alterations in mRNA and protein expression of glutamate transporters in rat hippocampus after paraoxon exposure. Neurotoxicology 2016; 57: 251-257.

  • 14.

    Zhou Y, Danbolt NC. GABA and Glutamate Transporters in Brain. Front Endocrinol (Lausanne) 2013; 4: 165.

  • 15.

    Mohammadi M, Zare Z. Effects of treadmill exercise on cognitive functions and anxiety-related behaviors in ovariectomized diabetic rats. Physiol Behav 2020; 224: 113021.

  • 16.

    Jafari A, Rostampour M, Ataei A, Khakpour-Taleghani B. Interaction of glutamatergic system inhibition and aerobic exercise on anxiety-like behaviors in rats. Koosmesh 2022; 24: 531-537. (Persian).

  • 17.

    Hampel H, Mesulam MM, Cuello AC, Farlow MR, Giacobini E, Grossberg GT, et al. The cholinergic system in the pathophysiology and treatment of Alzheimer's disease. Brain 2018; 141: 1917-1933.

  • 18.

    Atri A, Sherman S, Norman KA, Kirchhoff BA, Nicolas MM, Greicius MD, et al. Blockade of central cholinergic receptors impairs new learning and increases proactive interference in a word paired-associate memory task. Behav Neurosci 2004; 118: 223-236.

  • 19.

    Buccafusco JJ, Letchworth SR, Bencherif M, Lippiello PM. Long-lasting cognitive improvement with nicotinic receptor agonists: mechanisms of pharmacokinetic-pharmacodynamic discordance. Trends Pharmacol Sci 2005; 26: 352-360.

  • 20.

    Green A, Ellis KA, Ellis J, Bartholomeusz CF, Ilic S, Croft RJ, et al. Muscarinic and nicotinic receptor modulation of object and spatial n-back working memory in humans. Pharmacol Biochem Behav 2005; 81: 575-584.

  • 21.

    Tehrani Farzin F, Bananej M, Sahraei H. Involvement of muscarinic system of the dorsal hippocampus on acute stress-induced spatial learning and memory enhancement in male mice. Koomesh 2021; 23: 821-833. (Persian).

  • 22.

    Soreq H, Seidman S. Acetylcholinesterase--new roles for an old actor. Nat Rev Neurosci 2001; 2: 294-302.

  • 23.

    Caliskan H, Akat F, Tatar Y, Zaloglu N, Dursun AD, Bastug M, Ficicilar H. Effects of exercise training on anxiety in diabetic rats. Behav Brain Res 2019; 376: 112084.

  • 24.

    Zare Z, Zarbakhsh S, Tehrani M, Mohammadi M. Neuroprotective effects of treadmill exercise in hippocampus of ovariectomized and diabetic rats. Neuroscience 2022; 496: 64-72.

  • 25.

    Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-254.

  • 26.

    Zare Z, Tehrani M, Rafiei A, Valadan R, Mohammadi M. Differential expression of glutamate transporters in cerebral cortex of paraoxon-treated rats. Neurotoxicol Teratol 2017; 62: 20-26.

  • 27.

    Zare Z, Tehrani M, Rezaei N, Dana Ghalebarzand B, Mohammadi M. Anxiolytic activity of paraoxon is associated with alterations in rat brain glutamatergic system. Neurotoxicol Teratol 2019; 71: 32-40.

  • 28.

    Auger ML, Floresco SB. Prefrontal cortical GABAergic and NMDA glutamatergic regulation of delayed responding. Neuropharmacology 2017; 113: 10-20.

  • 29.

    Millard SJ, Lum JS, Fernandez F, Weston-Green K, Newell KA. Perinatal exposure to fluoxetine increases anxiety- and depressive-like behaviours and alters glutamatergic markers in the prefrontal cortex and hippocampus of male adolescent rats: A comparison between Sprague-Dawley rats and the Wistar-Kyoto rat model of depression. J Psychopharmacol 2019; 33: 230-243.

  • 30.

    Tinkler GP, Tobin JR, Voytko ML. Effects of two years of estrogen loss or replacement on nucleus basalis cholinergic neurons and cholinergic fibers to the dorsolateral prefrontal and inferior parietal cortex of monkeys. J Comp Neurol 2004; 469: 507-521.

  • 31.

    Martnez-Tellez R, Gmez-Villalobos Mde J, Flores G. Alteration in dendritic morphology of cortical neurons in rats with diabetes mellitus induced by streptozotocin. Brain Res 2005; 1048: 108-115.

  • 32.

    Zare Z, Tehrani M, Zarbakhsh S, Mohammadi M. Protective effects of treadmill exercise on apoptotic neuronal damage and astrocyte activation in ovariectomized and/or diabetic rat prefrontal cortex: molecular and histological aspects. Int J Neurosci 2022; 1-9.

  • 33.

    Thierry AM, Gioanni Y, Dgntais E, Glowinski J. Hippocampo-prefrontal cortex pathway: anatomical and electrophysiological characteristics. Hippocampus 2000; 10: 411-419.

  • 34.

    Wood JN. Social cognition and the prefrontal cortex. Behav Cogn Neurosci Rev 2003; 2: 97-114.

  • 35.

    Furman BL. Streptozotocin-Induced Diabetic Models in Mice and Rats. Curr Protoc 2021; 1: e78.

  • 36.

    Coleman E, Judd R, Hoe L, Dennis J, Posner P. Effects of diabetes mellitus on astrocyte GFAP and glutamate transporters in the CNS. Glia 2004; 48: 166-178.

  • 37.

    Nagayach A, Patro N, Patro I. Experimentally induced diabetes causes glial activation, glutamate toxicity and cellular damage leading to changes in motor function. Front Cell Neurosci 2014; 8: 355.

  • 38.

    Lu Y, Dong Y, Tucker D, Wang R, Ahmed ME, Brann D, et al. Treadmill exercise exerts neuroprotection and regulates microglial polarization and oxidative stress in a streptozotocin-induced rat model of sporadic Alzheimer's disease. J Alzheimers Dis 2017; 56: 1469-1484.

  • 39.

    Baydas G, Nedzvetskii VS, Tuzcu M, Yasar A, Kirichenko SV. Increase of glial fibrillary acidic protein and S-100B in hippocampus and cortex of diabetic rats: effects of vitamin E. Eur J Pharmacol 2003; 462: 67-71.

  • 40.

    Saravia FE, Revsin Y, Gonzalez Deniselle MC, Gonzalez SL, Roig P, Lima A, et al. Increased astrocyte reactivity in the hippocampus of murine models of type 1 diabetes: the nonobese diabetic (NOD) and streptozotocin-treated mice. Brain Res 2002; 957: 345-353.

  • 41.

    Sullivan SM, Lee A, Bjrkman ST, Miller SM, Sullivan RK, Poronnik P, et al. Cytoskeletal anchoring of GLAST determines susceptibility to brain damage: an identified role for GFAP. J Biol Chem 2007; 282: 29414-29423.

  • 42.

    Crino PB, Jin H, Shumate MD, Robinson MB, Coulter DA, Brooks-Kayal AR. Increased expression of the neuronal glutamate transporter (EAAT3/EAAC1) in hippocampal and neocortical epilepsy. Epilepsia 2002; 43: 211-218.

  • 43.

    Hsu PC, Lan YJ, Chen CC, Lee LY, Chen WP, Wang YC, Lee YH. Erinacine A attenuates glutamate transporter 1 downregulation and protects against ischemic brain injury. Life Sci 2022; 306: 120833.

  • 44.

    Groeneveld ON, van den Berg E, Johansen OE, Schnaidt S, Hermansson K, Zinman B, et al. Oxidative stress and endothelial dysfunction are associated with reduced cognition in type 2 diabetes. Diab Vasc Dis Res 2019; 16: 577-581.

  • 45.

    Kong FJ, Ma LL, Guo JJ, Xu LH, Li Y, Qu S. Endoplasmic reticulum stress/autophagy pathway is involved in diabetes-induced neuronal apoptosis and cognitive decline in mice. Clin Sci (Lond) 2018; 132: 111-125.

  • 46.

    Sofroniew MV. Reactive astrocytes in neural repair and protection. Neuroscientist 2005; 11: 400-407.

  • 47.

    Schmatz R, Mazzanti CM, Spanevello R, Stefanello N, Gutierres J, Corra M, et al. Resveratrol prevents memory deficits and the increase in acetylcholinesterase activity in streptozotocin-induced diabetic rats. Eur J Pharmacol 2009; 610: 42-48.

  • 48.

    Danbolt NC. Glutamate uptake. Prog Neurobiol 2001; 65: 1-105.